On 20 October ZOLL Medical Corporation and CAIRE, Inc., announced a distribution agreement whereby ZOLL has exclusive rights to distribute the latter’s SAROS 4000 Portable Oxygen Concentrator in all markets outside the US, in combination with the ZOLL EMV+ ventilator. By combining the two devices, remote medics will be able to deliver high-end, oxygen-enriched critical care ventilation and oxygenation therapy without the use of oxygen cylinders.
The transport, recycling, refilling and logistical challenges associated with portable oxygen containers in the field is a problem that has beset modern military medical practitioners for decades. Potentially hazardous to remote medical teams in armed conflicts and first responders in emergency situations, any solution that mitigates the associated risks has major potential for commercial success.
“The logistical burden of exchanging empty oxygen cylinders in the field presents considerable challenges for militaries, including the risk of explosion and the need for aircraft and personnel to transport the cylinders to and from the field,” explained Elijah A White, President of ZOLL Resuscitation. “This is a game-changing advancement for all military medical services and disaster relief organisations in their efforts to provide lifesaving therapies during their missions.”
“SAROS broke new ground as the first and only oxygen concentrator designed specifically for military use,” observed Earl Lawson, President and CEO of CAIRE. “Our agreement with ZOLL enables us to increase global access to this important technology. Coupled with the EMV+ ventilator, it will dramatically improve the delivery of care in emergent situations.”